NYSE:USNA - USANA Health Sciences Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $126.00
  • Forecasted Upside: 24.53 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$101.18
▲ +1.36 (1.36%)

This chart shows the closing price for USNA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New USANA Health Sciences Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for USNA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for USNA

Analyst Price Target is $126.00
▲ +24.53% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for USANA Health Sciences in the last 3 months. The average price target is $126.00, with a high forecast of $126.00 and a low forecast of $126.00. The average price target represents a 24.53% upside from the last price of $101.18.

This chart shows the closing price for USNA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in USANA Health Sciences. This rating has held steady since April 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/1/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/1/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/30/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/26/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/25/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/25/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/10/2021Roth CapitalBoost Price TargetBuy$107.00 ➝ $126.00Low
12/17/2020Roth CapitalInitiated CoverageBuy$107.00Low
5/12/2020Tigress FinancialReiterated RatingBuyLow
8/22/2019Jefferies Financial GroupInitiated CoverageHold$65.00Medium
7/24/2019Pivotal ResearchReiterated RatingBuyLow
7/3/2019Pivotal ResearchReiterated RatingBuy$75.00High
7/3/2019SidotiDowngradeBuy ➝ Neutral$70.00High
5/1/2019Pivotal ResearchReiterated RatingBuy$105.00High
4/16/2019Tigress FinancialInitiated CoverageBuy ➝ BuyLow
10/25/2018SidotiUpgradeNeutral ➝ BuyLow
10/24/2018Pivotal ResearchUpgradeHold ➝ Buy$135.00High
7/25/2018Pivotal ResearchReiterated RatingHold$135.00Medium
4/23/2018Pivotal ResearchDowngradeBuy ➝ Hold$95.00High
2/7/2018Pivotal ResearchBoost Price TargetBuy$80.00 ➝ $95.00Medium
1/24/2018SidotiDowngradeBuy ➝ NeutralMedium
10/25/2017Pivotal ResearchBoost Price TargetBuy$70.00 ➝ $80.00N/A
7/26/2017Pivotal ResearchLower Price TargetBuy ➝ Buy$75.00 ➝ $70.00High
5/3/2017Pivotal ResearchUpgradeHold ➝ Buy$55.00 ➝ $75.00Low
5/1/2017Pivotal ResearchReiterated RatingBuy ➝ Hold$75.00 ➝ $55.00Low
2/8/2017Pivotal ResearchLower Price TargetBuy$80.00 ➝ $75.00N/A
7/28/2016DA DavidsonBoost Price TargetNeutral$135.00 ➝ $150.00N/A
(Data available from 7/25/2016 forward)
USANA Health Sciences logo
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Read More

Today's Range

Now: $101.18
Low: $99.06
High: $101.44

50 Day Range

MA: $102.39
Low: $99.72
High: $106.00

52 Week Range

Now: $101.18
Low: $72.03
High: $107.85

Volume

34,140 shs

Average Volume

47,754 shs

Market Capitalization

$2.09 billion

P/E Ratio

16.64

Dividend Yield

N/A

Beta

0.9

Frequently Asked Questions

What sell-side analysts currently cover shares of USANA Health Sciences?

The following Wall Street research analysts have issued research reports on USANA Health Sciences in the last twelve months: Roth Capital, and Zacks Investment Research.
View the latest analyst ratings for USNA.

What is the current price target for USANA Health Sciences?

1 Wall Street analysts have set twelve-month price targets for USANA Health Sciences in the last year. Their average twelve-month price target is $126.00, suggesting a possible upside of 24.5%. Roth Capital has the highest price target set, predicting USNA will reach $126.00 in the next twelve months. Roth Capital has the lowest price target set, forecasting a price of $126.00 for USANA Health Sciences in the next year.
View the latest price targets for USNA.

What is the current consensus analyst rating for USANA Health Sciences?

USANA Health Sciences currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe USNA will outperform the market and that investors should add to their positions of USANA Health Sciences.
View the latest ratings for USNA.

What other companies compete with USANA Health Sciences?

How do I contact USANA Health Sciences' investor relations team?

USANA Health Sciences' physical mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company's listed phone number is 801-954-7100 and its investor relations email address is [email protected] The official website for USANA Health Sciences is www.usana.com.